The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Open accessAbstract
Aims/Introduction: The aim of the present study was to investigate the association between diabetes and the risk of all type dementia ( ATD ), A lzheimer's disease ( AD ) and vascular dementia ( VaD ). Materials and Methods: Prospective observational studies describing the incidence of ATD , AD and VaD in patients with diabetes mellitus were extracted from PubMed, EMBASE and other databases up to January 2012. Pooled relative risk ( RR ) estimates and 95% confidence intervals ( CI s) were calculated using the random‐effects model. Subgroup analyses and sensitivity analysis were also carried out. Results: A total of 28 studies contributed to the analysis. Pooled RR of developing ATD ( n = 20) was 1.73 (1.65–1.82, I 2 = 71.2%), AD ( n = 20) was 1.56 (1.41–1.73, I 2 = 9.8%) and VaD ( n = 13) was 2.27 (1.94–2.66, I 2 = 0%) in patients with diabetes mellitus. Higher and medium quality studies did not show any significant difference for pooled RR for ATD , AD or VaD . Sensitivity analyses showed robustness of pooled RR among ATD , AD and VaD , showing no single study had a major impact on pooled RR . Conclusions: The results showed a 73% increased risk of ATD , 56% increase of AD and 127% increase of VaD in diabetes patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These factors include hypertension 85,[105][106][107] and diabetes.[108][109][110]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [108]
In the citing paper
“A meta-analysis of prospective and observational studies in PWD showed a 73% increased risk of all types of dementia, a 56% increased risk of Alzheimer dementia, and a 127% increased risk of vascular dementia compared with individuals without diabetes (115).”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [115]
In the citing paper
“A meta-analysis of prospective and observational studies in PWD showed a 73% increased risk of all types of dementia, a 56% increased risk of Alzheimer dementia, and a 127% increased risk of vascular dementia compared with individuals without diabetes (115).”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [115]
In the citing paper
“A meta-analysis of prospective and observational studies in PWD showed a 73% increased risk of all types of dementia, a 56% increased risk of Alzheimer dementia, and a 127% increased risk of vascular dementia compared with individuals without diabetes (115).”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
(2014) · Medical Entomology and Zoology · Cited by 17,633
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 2×
“Seven out of 10 studies by Biessels et al.47 and five out of nine studies by Kloppenborg et al.53 reported a higher risk of dementia in patients with diabetes.”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00074.x · Cited by 1,799
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Research works printed but not linked: 1
- Alzheimer's Disease International, 2008, The Prevalence of Dementia Worldwide
Cited by
Sorted by citations
Items 701–726 of 726
de Leijer, J. F., Biessels, G. J., Visseren, F. L. J., & van Sloten, T. T. (2026) · Diabetologia · doi:10.1007/s00125-026-06795-2
“Although observational studies show that type 2 diabetes increases the risk of a clinical diagnosis of Alzheimer’s disease [52], the burden of Alzheimer’s disease neuropathology (i.e. amyloid-β and tau deposits) does not appear to be increased in individuals with type 2 diabetes [53–56].”
Li, Y., Wang, S. S., Xie, K., Qian, S., Ma, M., & Zhang, H. (2026) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2026146
Cassataro, G., Scriffignano, S., Geraci, G., Augello, G., Grasso, M. A., D’Ippolito, M. E., Puleo, M. G., Cadelo, M., Renda, M., & Tuttolomondo, A. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04468-x · Cited by 1
Ali, A., Maqsood, A., Mustafa, A., Hussain, Z., Ashraf, A., Sarfaraz, S., Butt, A., Shamoon, M., Ghafoor, L. A., Azam, H., et al. (2026) · Brain and Behavior · doi:10.1002/brb3.71616
“…studies have consistently demonstrated that diabetes is a significant risk factor for cognitive decline and dementia, with meta-analyses showing a 50%–100% increased risk of Alzheimer’s disease and vascular dementia among individuals with diabetes (Gudala et al. 2013 ; Chatterjee et al. 2016 ).”
Surguchov, A. P. (2026) · Biomedicines · doi:10.3390/biomedicines14081709
“Accumulating epidemiological and experimental evidence indicates that these two disorders are closely interconnected, leading to the concept of AD as “type 3 diabetes” or a brain-specific insulin-resistant state [4–6].”
Cognitive links with brain insulin signaling in metabolism: A new narrative
Yaribeygi, H., & Forouzanmehr, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30263-3.00030-0
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_9
Novotný, J., Klil‐Drori, S., Geda, Y. E., Nasreddine, Z. S., & Stokin, G. B. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100649 · Cited by 1
“…in life and may include conditions such as anxiety [51], depression [52 – 54], psychiatric illnesses [55,56], functional cognitive disorders [57,58], cerebral vascular diseases [18,59 – 61], traumatic brain injury [62,63], as well as systemic causes such as obesity [64] and diabetes [54,65,66].”
Wang, N., Wang, T., Mao, X., Huang, L., & Chen, H. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-026-01423-6
“Mean-while, some studies have suggested that diabetes significantly increases the risk of developing dementia [25–27].”
Watanabe, N., Ogawa, A., Osada, T., Adachi, Y., Shirokoshi, T., Kodama, H., Oshima, Y., Tanaka, S., Kaga, H., Tamura, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742662
Xu, L.-J., Huang, L.-Y., Tang, S., Zou, J., Tan, C., Tan, L., & Xu, W. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106978
Sharif, A., Mamo, J. C. L., Lam, V., Watts, G. F., Luna, G., Nesbit, M., Al‐Salami, H., Mooranian, A., & Takechi, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1826957 · Cited by 1
“Diabetes mellitus, particularly type 2 diabetes (T2D), is associated with cognitive impairment, anxiety, and an increased risk of dementia, including Alzheimer’s disease (AD) and related dementias (Gudala et al., 2013; Smith et al., 2013).”
Vascular cognitive impairment and dementia: current understanding and future directions
Garg, S., & McCullough, L. D. (2026) · npj Dementia · doi:10.1038/s44400-026-00135-2
“Across cohorts, individuals with diabetes show a 1.4 – 2.2-fold higher incidence of dementia compared to those without the disease 101,102 .”
InfluentialModifiable Risk Factors for Dementia across the Europe: regional comparative studyusing SHARE dataPreprint
Kučera, M., Meertens, E., Groot, J., Tange, M., Šeblová, D., Bosmans, J. E., Kearns, P. B., & Broulíková, H. M. (2026) · Research Square · doi:10.21203/rs.3.rs-9835142/v1
Cognitive impairments in prediabetes and diabetes: From pathogenesis to comprehensive therapy
Пизова, Н. В., Pizov, A. V., & Solovyov, I. N. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-305
Zhao, S., Sui, S., Guo, X., Ji, X., Liu, T., & Yang, H. (2026) · Cells · doi:10.3390/cells15181672
Knezović, A., Krsnik, A., Homolak, J., Perhoč, A. B., Deškin, A., Virag, D., Šalković‐Petrišić, M., & Barilar, J. O. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106982
Zhang, T., Chen, X., Wang, Y., & Wang, Y. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02598-7
“Although meta-analyses indicate a 1.5-to twofold increased AD risk in T2D populations (Zhang et al. 2017 ; Gudala et al. 2013), recent large-scale Mendelian randomization studies have not supported a direct genetic causal effect (Larsson and Markus 2018 ; Østergaard et al. 2015 ).”
InfluentialHexokinase-2–glycolytic overload axis in brain disorders exacerbated by diabetes
Alhujaily, M. M., Rabbani, N., & Thornalley, P. J. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.09.006
Heart and Brain: Linking Obesity-Related Inflammation, Cardiovascular Disease and Cognitive Function
Reiss, A. B., Gulkarov, S., Syed, U., Ben-Dor, G. A., Srivastava, A., Singh, M., & Leon, J. D. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13100477
“Earlier meta-analytic work also reported increased risk of all-type dementia, Alzheimer’s disease, and vascular dementia among individuals with diabetes [173].”
Zhang, Z., Chen, C., Chen, Z., Guo, Y., Feng, Y., Liu, D., Wen, Y., Yun, P., & Lin, X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06226-8
Lodha, S. M., Kumar, S., Acharya, S., Baweja, R., & Garg, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10923165/v1
Potential links between PCOS/PMOS and Alzheimer disease and related dementias
Amiri, M., Hamidi, A. K., Farkas, D. L., Buyalos, R. P., & Azziz, R. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag206
“PCOS/ PMOS-related lipid disturbances may therefore converge with AD pathways involving oxidative stress, mitochondrial dysfunction, and neuroinflammation (119, 120), but are heavily influenced by the concomitant obesity and IR.”
Dewer, M. A., Dawod, S. G., Elbadawy, N. M., & Bassiouny, E. A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00345-7
“Epidemiological studies and meta-analyses have consistently shown that individuals with T2DM have an approximately 50% higher risk of developing dementia, including AD, compared with those without diabetes [4].”
Diabetes Mellitus: Review of the Common, Rare, and Uncommon (Conceptual and Metaphorical) Types
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219611
Al‐Shaikh, J. H., Ghosh‐Swaby, O. R., KHAN, A. R., Thornton, J., Bussey, T. J., Saksida, L. M., Palmer, D. D., Liu-Ambrose, T. Y. L., & Nagamatsu, L. S. (2026) · Hippocampus · doi:10.1002/hipo.70144
“Results from a meta-analysis suggest that individuals with T2D have a 56% increased risk for developing Alzheimer's disease (Gudala et al. 2013).”
Metadata
- Authors
- Gudala, K., Bansal, D., Schifano, F., & Bhansali, A.
- Affiliations
- National Institute of Pharmaceutical Education and Research (IN)
- University of Hertfordshire (GB)
- Post Graduate Institute of Medical Education and Research (IN)
- Corresponding author
- Bansal, Dipika
- Venue
- Journal of Diabetes Investigation
- Publisher
- Wiley
- Published
- 2013-04-26
- Volume
- 4
- Issue
- 6
- Pages
- 640-650
- ISSN
- 2040-1116 (ISSN-L)
- 2040-1124
- PMC
- PMC4020261
- OpenAlex
- W2035873080
- Cited by
- 727
- References
- 57
- Citations by year
- 2026: 69 · 2025: 90 · 2024: 73 · 2023: 61 · 2022: 84 · 2021: 61 · 2020: 80 · 2019: 66 · 2018: 37 · 2017: 44 · 2016: 35 · 2015: 20 · 2014: 5
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Diabetes Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- diabetes mellitus, dementia, Alzheimer's disease, vascular dementia, dementia risk, incidence, type 2 diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
